StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > US$40 million Agreement

<< Previous

Bullboard Posts

Next >>

Comment by Bucky86on Feb 15, 2021 2:51pm

164 Views

Post# 32569077

RE:RE:RE:US$40 million Agreement

I love how people on the Stockhouse BB think that the actions of a few here have such a massive affect on the stock price... absolute joke. CBD, you actually think that the 15-20 simpletons (myself included) on stockhouse make a "big" impact on the stock price? honestly its hilarious....
ive said it for years now....whether you pump or dump it means NOTHING for the stock.
market sentiment (not on stockhouse) and the company's actions comprise 99.5% of the stocks activity. I remember now why I took a break from SH

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages